Page 5 - Astellas Urological News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Astellas urological. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Astellas Urological Today - Breaking & Trending Today

EMA Accepts Marketing Application for Zolbetuximab in CLDN18.2+ Gastric/GEJ Adenocarcinoma

The European Medicines Agency has accepted a marketing authorization application seeking the approval of zolbetuximab for first-line treatment of patients with Claudin18.2-positive, HER2-negative, unresectable, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma. ....

Moitreyee Chatterjee Kishore , Oncology Development At Astellas , European Medicines Agency , Immuno Oncology Development , Medicines Agency , Patients With Claudin18 2 Positive , Her2 Negative , Ocally Advanced Or Metastatic Gastric Gastroesophageal Junction Adenocarcinoma , Spotlight Trial , Glow Trial ,

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Zolbetuximab

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Zolbetuximab
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Moitreyee Chatterjee Kishore , Naoki Okamura , Oncology Development , Astellas Pharma Inc , European Commission , Committee For Medicinal Products Human Use , European Medicines Agency , Senior Vice President , Immuno Oncology Development , Medicinal Products , Human Use , Press Release Image , First In Class , Ldn182 Targeted , First Line , Her2 Negative , Press Release , Ews Release ,

China's revised anti-spying law raises concerns for Japanese firms

China recently revised counterespionage law has raised concerns among Japanese firms and individuals, as it poses a risk of detention for unclear reasons, J ....

United States , Naoki Tsukioka , Tetsuro Homma , Astellas Pharma , Li Qiang , Akio Takahara , European Union Chamber , School Of Public , Mizuho Research , University Of Tokyo , Japanese Chamber , World Economic Forum , Chinese Foreign Ministry , Japan Times , Premier Li Qiang , Mao Ning , Graduate School , Public Policy , Europe News , He Japanese ,

Phase 3b Trial of Fezolinetant Shows Positive Topline Results for Treatment of VMS Due to Menopause

Phase 3b Trial of Fezolinetant Shows Positive Topline Results for Treatment of VMS Due to Menopause
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Naoki Okamura , Drug Administration , Head Of Biopharma Development , Astellas Pharma Inc , Fezolinetant Shows Positive Topline Results , Vice President , Biopharma Development , Press Release Image , Press Release , Ews Release ,

Astellas Submits New Drug Application for Zolbetuximab in Japan

Astellas Submits New Drug Application for Zolbetuximab in Japan
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Pranob Bhattacharya , Naoki Okamura , Ministry Of Health , Astellas Pharma Inc , Oncology Development , Drug Application To Japan Ministry Of Health , Japan Ministry Of Health , Astellas Submits New Drug Application , New Drug Application , Executive Director , Interim Head , Immuno Oncology Development , Press Release Image , First In Class , Ldn182 Targeted , First Line , Her2 Negative , Press Release , Ews Release ,